durapatite has been researched along with ro13-9904 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Assadi, MJ; Al-Sokanee, ZN; Alassadi, EA; Toabi, AA | 1 |
| Basu, D; Bhattacharya, RN; Dandapat, N; Datta, BK; Kundu, B; Mandal, TK; Mukherjee, P; Nandi, SK; Roy, S; Soundrapandian, C | 1 |
2 other study(ies) available for durapatite and ro13-9904
| Article | Year |
|---|---|
The drug release study of ceftriaxone from porous hydroxyapatite scaffolds.
Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Bone and Bones; Buffers; Cattle; Ceftriaxone; Delayed-Action Preparations; Drug Compounding; Durapatite; Glucose; In Vitro Techniques; Phosphates; Porosity; Solubility; Solutions; Spectroscopy, Fourier Transform Infrared; Temperature; Thermogravimetry; X-Ray Diffraction | 2009 |
Development of new localized drug delivery system based on ceftriaxone-sulbactam composite drug impregnated porous hydroxyapatite: a systematic approach for in vitro and in vivo animal trial.
Topics: Animals; Anti-Bacterial Agents; Ceftriaxone; Disease Models, Animal; Drug Compounding; Drug Delivery Systems; Durapatite; Hydrogen-Ion Concentration; Microscopy, Electron, Scanning; Osteomyelitis; Porosity; Powders; Rabbits; Staphylococcus aureus; Sulbactam; X-Ray Diffraction | 2010 |